| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-05 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |